arrow
C

Carsten Schade Larsen

Aarhus University Hospital
H指数:41
被引数:6,417

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From Validation to Clinical Interpretation: A Flow Cytometric Th17-Cell Assay for STAT1- and STAT3-Related Inborn Errors of Immunity

从验证到临床解释:一种用于STAT1和STAT3相关免疫先天性缺陷的流式细胞术Th17细胞检测方法

2026-09-300
OAAI
Novel Partial Loss-of-function STAT3-variant as Cause of Hyper-IgE-Syndrome in a Danish Family with Variable Expressivity

一种新型部分功能缺失型STAT3变异体作为具有可变表达性的丹麦家族中高IgE综合征的病因

2026-06-080
OAAI
Electronic nudges to increase influenza vaccination uptake in younger and middle-aged individuals with atrial fibrillation: a prespecified analysis of the NUDGE-FLU-CHRONIC trial

对心房颤动年轻及中年个体通过电子提醒提高流感疫苗接种率:NUDGE-FLU-CHRONIC试验的预先指定分析

2026-01-010
PRE
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease

高剂量与标准剂量流感疫苗在慢性肾脏疾病中的应用

JACC
IF0
2025-11-260
OAAI
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Atrial Fibrillation

高剂量与标准剂量流感疫苗在房颤老年患者中的应用比较

JACC
IF0
2025-11-260
OAAI
Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trial
2025-11-010
OAAI
Digital Nudges to Increase Influenza Vaccination in Patients with Chronic Diseases
2025-11-012
PRE
High-Dose vs. Standard-Dose Influenza Vaccine in Older Patients With Hypertension: A Post Hoc Analysis of DANFLU-1

高血压老年患者中高剂量与标准剂量流感疫苗的比较:DANFLU-1的事后分析

2025-11-010
OAAI
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis

高剂量流感疫苗对老年人住院的疗效(FLUNITY-HD):一项基于个体水平的合并分析

2025-10-170
PRE
Effect of RSV Vaccine on Heart Failure Hospitalizations

RSV疫苗对心力衰竭住院的影响

JACC
IF0
2025-08-300
PRE
A Bayesian re-analysis of the DANFLU-1 trial

DANFLU-1试验的贝叶斯再分析

2025-08-250
OAAI
Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccination Against Hospitalizations and Deaths According to Frailty Score: A Post Hoc Analysis of the DANFLU-1 Randomized Trial

根据虚弱评分,高剂量与标准剂量流感疫苗接种在预防住院和死亡方面的相对有效性:DANFLU-1随机试验的事后分析

2025-08-011
PRE
Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trial

二价呼吸道合胞病毒前融合F蛋白疫苗在有无动脉粥样硬化性心血管疾病个体中的有效性:DAN-RSV试验

2025-08-012
OAAI
High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trial

高剂量与标准剂量灭活流感疫苗及在有无原有动脉粥样硬化性心血管疾病人群中心血管结局:DANFLU-2试验

2025-08-012
OAAI
A Pragmatic Individually Randomized Trial to Evaluate the Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccine in Older Adults: Rationale and Design of the DANFLU-2 Trial

一项实用型个体随机对照试验,旨在评估高剂量与标准剂量流感疫苗在老年人群中的有效性:DANFLU-2试验的原理与设计

2025-07-300
OAAI
A Pragmatic Individually Randomized Trial to Evaluate Bivalent RSV Prefusion F Protein–based Vaccine Effectiveness for Preventing RSV Hospitalizations in Adults Aged 60 Years or Above (DAN-RSV): Rationale & Trial Design

一项实用性个体随机试验,旨在评估双价RSV预融合F蛋白疫苗对预防60岁及以上成人RSV住院的有效性(DAN-RSV):研究依据与试验设计

2025-07-280
OAAI